CAS 114903-05-8
:Fondaparinux-Natrium N-3
Beschreibung:
Fondaparinux-Natrium, mit der CAS-Nummer 114903-05-8, ist ein synthetisches Antikoagulans, das zur Klasse der Medikamente gehört, die als Pentasaccharide bekannt sind. Es wird hauptsächlich zur Prävention und Behandlung von venösen Thromboembolien eingesetzt und ist besonders wirksam bei Patienten, die sich einer orthopädischen oder abdominalen Chirurgie unterziehen. Fondaparinux wirkt, indem es selektiv den Faktor Xa hemmt, ein essentielles Element in der Gerinnungskaskade, wodurch die Bildung von Blutgerinnseln verhindert wird. Diese Verbindung zeichnet sich durch ihre hohe Bioverfügbarkeit und vorhersehbare Pharmakokinetik aus, was eine subkutane Verabreichung ohne routinemäßige Überwachung der Gerinnungsparameter ermöglicht. Fondaparinux-Natrium ist wasserlöslich und hat ein relativ niedriges Molekulargewicht, was zu seinem günstigen pharmakologischen Profil beiträgt. Darüber hinaus hat es eine lange Halbwertszeit, die eine einmal tägliche Dosierung unterstützt. Wie bei jedem Antikoagulans ist es wichtig, mögliche Blutungskomplikationen und Kontraindikationen zu überwachen, insbesondere bei Patienten mit Niereninsuffizienz oder aktiven Blutungsstörungen.
Formel:C81H91N7O27
InChl:InChI=1S/C81H91N7O27/c1-99-76-58(84-81(98)106-46-53-35-21-8-22-36-53)65(101-41-48-25-11-3-12-26-48)64(56(39-91)107-76)111-79-61(93)67(103-43-50-29-15-5-16-30-50)69(71(114-79)74(94)95)112-77-57(85-87-82)60(92)62(54(37-89)108-77)110-80-73(105-45-52-33-19-7-20-34-52)68(104-44-51-31-17-6-18-32-51)70(72(115-80)75(96)97)113-78-59(86-88-83)66(102-42-49-27-13-4-14-28-49)63(55(38-90)109-78)100-40-47-23-9-2-10-24-47/h2-36,54-73,76-80,89-93H,37-46H2,1H3,(H,84,98)(H,94,95)(H,96,97)/t54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68+,69+,70+,71-,72+,73-,76+,77-,78-,79-,80-/m1/s1
InChI Key:InChIKey=YJFUPTPXBAYHGB-JFHRUGPCSA-N
SMILES:O([C@H]1[C@H](OCC2=CC=CC=C2)[C@@H](OCC3=CC=CC=C3)[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@H]5[C@H](OCC6=CC=CC=C6)[C@@H](O)[C@H](O[C@H]7[C@H](OCC8=CC=CC=C8)[C@@H](NC(OCC9=CC=CC=C9)=O)[C@@H](OC)O[C@@H]7CO)O[C@H]5C(O)=O)[C@H](N=[N+]=[N-])[C@H]4O)O[C@@H]1C(O)=O)[C@@H]%10[C@H](N=[N+]=[N-])[C@@H](OCC%11=CC=CC=C%11)[C@H](OCC%12=CC=CC=C%12)[C@@H](CO)O%10
Synonyme:- Fondaparinux Sodium intermediate N-3
- Methyl O-2-azido-2-deoxy-3,4-bis-O-(phenylmethyl)-α-<span class="text-smallcaps">D</smallcap>-glucopyranosyl-(1→4)-O-2,3-bis-O-(phenylmethyl)-β-<smallcap>D</smallcap>-glucopyranuronosyl-(1→4)-O-2-azido-2-deoxy-α-<smallcap>D</smallcap>-glucopyranosyl-(1→4)-O-3-O-(phenylmethyl)-α-<smallcap>L</smallcap>-idopyranuronosyl-(1→4)-2-deoxy-2-[[(phenylmethoxy)carbonyl]amino]-3-O-(phenylmethyl)-α-<smallcap>D</span>-glucopyranoside
- Methyl-O-(2-azido-3,4-di-O-benzyl-2-deoxy-a-D-glucopyranosyl)-(1-4)-O-(2,3-di-Obenzyl-β-D-glucopyranosyluronicacid)-(1-4)-O-(2-azido-2-deoxy-a-D-glucopyranosyl)-(1-4)-O-(3-O-benzyl-a-L-idopyranosyluronic acid)-(1-4)-3-O-benzyl-2-benzyloxycarbonylamino-2-deoxy-a-D-glucopyranoside
- N-3 Intermediate, Fondaparinux
- N-3 for Fondaparinux sodium
- Pentasaccharide N-3 Intermediate
- α-<span class="text-smallcaps">D</smallcap>-Glucopyranoside, methyl O-2-azido-2-deoxy-3,4-bis-O-(phenylmethyl)-α-<smallcap>D</smallcap>-glucopyranosyl-(1→4)-O-2,3-bis-O-(phenylmethyl)-β-<smallcap>D</smallcap>-glucopyranuronosyl-(1→4)-O-2-azido-2-deoxy-α-<smallcap>D</smallcap>-glucopyranosyl-(1→4)-O-3-O-(phenylmethyl)-α-<smallcap>L</span>-idopyranuronosyl-(1→4)-2-deoxy-2-[[(phenylmethoxy)carbonyl]amino]-3-O-(phenylmethyl)-
- Methyl O-2-azido-2-deoxy-3,4-bis-O-(phenylmethyl)-α-D-glucopyranosyl-(1→4)-O-2,3-bis-O-(phenylmethyl)-β-D-glucopyranuronosyl-(1→4)-O-2-azido-2-deoxy-α-D-glucopyranosyl-(1→4)-O-3-O-(phenylmethyl)-α-L-idopyranuronosyl-(1→4)-2-deoxy-2-[[(phenylmethoxy)carbonyl]amino]-3-O-(phenylmethyl)-α-D-glucopyranoside
- α-D-Glucopyranoside, methyl O-2-azido-2-deoxy-3,4-bis-O-(phenylmethyl)-α-D-glucopyranosyl-(1→4)-O-2,3-bis-O-(phenylmethyl)-β-D-glucopyranuronosyl-(1→4)-O-2-azido-2-deoxy-α-D-glucopyranosyl-(1→4)-O-3-O-(phenylmethyl)-α-L-idopyranuronosyl-(1→4)-2-deoxy-2-[[(phenylmethoxy)carbonyl]amino]-3-O-(phenylmethyl)-
- Methyl-O-(2-azido-3,4-di-O-benzyl-2-deoxy-a-D-glucopyranosyl)-(1-4)-O-(2,3-di-O-benzyl-b-D-glucopyranosyluronicacid)- (1-4)-O-(2-azido-2-deoxy-a-D-glucopyranosyl)-(1-4)-O-(3-O-benzyl-a-L-idopyranosyluronic acid)-(1-4)-3-O-benzyl- 2-benzyloxycarbonylamino-2-deoxy-a-D-glucopyranoside
- -4-(benzyloxy)-6-methoxytetrahydr
- Methyl O-2-Azido-2-deoxy-3,4-bis-O-(phenylmethyl)-α-D-glucopyranosyl-(1→4)-O-2,3-bis-O-(phenylmethyl)-β-D-glucopyranuronosyl-(1→4)-O-2-azido-2-deoxy-α-D-glucopyranosyl-(1→4)-O-3-O-(phenylmethyl)-α-L-i
- a-D-Glucopyranoside, Methyl O-2-azido-2-deoxy-3,4-bis-O-(phenylMethyl)-a-D-glucopyranosyl-(14) -O-2,3-bis-O-(phenylMethyl)-b-D-glucopyranuronosyl-(14)-O-2-azido- 2-deoxy-a-D-glucopyranosyl-(14)-O-3-O-(phenylMethyl)-a-L-idopyranu ronosyl-(14)-2-deoxy-2 ISO 9001:2015 REACH
- Fondaparinux Sodium intermediate N3
- Fondaparinux interMediate N-3
- Methyl O-2-azido-2-deoxy-3,4-bis-O-(phenylmethyl)-alpha-D-glucopyranosyl-(1→
- Methyl O-2-azido-2-deoxy-3,4-bis-O-(phenylmethyl)-alpha-D-glucopyranosyl-(1-4)-O-2,3-bis-O-(phenylmethyl)-beta-D-glucopyranuronosyl-(1-4)-O-2-azido-2-deoxy-alpha-D-glucopyranosyl-(1-4)-O-3-O-(phenylmethyl)-alpha-L-idopyranuronosyl-(1-4)-2-deoxy-2-[[(phenylmethoxy)carbonyl]amino]-3-O-(phenylmethyl)-alpha-D-glucopyranoside
- (((2R,3S,4R,5R,6S)-5-azido-2-((benzoyloxy)methyl)
- Fondaparinux Sodium N3 Intermediate
- -2H-pyran-2-yl)oxy)-6-
- US-DMF No.: 028552
- Fondaparinux sodiuM N-3
- N-3 Fondaparinux API
- Fondaparinux Sodium intermediate
- Methyl O-2-azido-2-deoxy-3,4-bis-O-(phenylmethyl)-alpha-D-glucopyranosyl-(1→4)-O-2,3-bis-O-(phenylmethyl)-beta-D-glucopyranuronosyl-(1→4)-O-2-azido-2-deoxy-alpha-D-glucopyranosyl-(1→4)-O-3-O-(phenylmethyl)-alpha-L-idopyranuronosyl-(1→4)-2-deoxy-2-[[(pheny
- 4)-O-2,3-bis-O-(phenylmethyl)-beta-D-glucopyranuronosyl-(1→
- -3-azido-4,5-bis(benzyloxy)tetrahydro
- 4)-O-2-azido-2-deoxy-alpha-D-glucopyranosyl-(1→
- 4)-2-deoxy-2-[[(phenylmethoxy)carbonyl]amino]-3-O-(phenylmethyl)-alpha-D-glucopyranoside
- a-D-Glucopyranoside,MethylO-2-azido-2-deoxy-3,4-bis-O-(phenylMethyl)-a-D-glucopyranosyl-(14)-O-2,3-bis-O-(phenylMethyl)-b-DChemicalbook-glucopyranuronosyl-(14)-O-2-azido-2-deoxy-a-D-glucopyranosyl-(14)-O-3-O-(phenylMethyl)-a-L-idopyranuronosyl-(14)-2-deoxy-2
- 4)-O-3-O-(phenylmethyl)-alpha-L-idopyranuronosyl-(1→
- a-D-Glucopyranoside, Methyl O-2-azido-2-deoxy-3,4-bis-O-(phenylMethyl)-a-D-glucopyranosyl-(14) -O-2,3-bis-O-(phenylMethyl)-b-D-glucopyranuronosyl-(14)-O-2-azido- 2-deoxy-a-D-glucopyranosyl-(14)-O-3-O-
- a-D-Glucopyranosid
- a-D-Glucopyranoside, Methyl O-2-azido-2-deoxy-3,4-bis-O-(phenylMethyl)-a-D-glucopyranosyl-(14) -O-2,3-bis-O-(phenylMethyl)-b-D-glucopyranuronosyl-(14)-O-2-azido- 2-deoxy-a-D-glucopyranosyl-(14)-O-3-O-(phenylMethyl)-a-L-idopyranu ronosyl-(14)-2-deoxy-2
- (((2R,3S,4R,5R,6R)-5-azido-6-(((2S,3S,4S,5R,6R)-6-
- (2S,3S,4S,5R,6R)-methyl 3-(((2R,3S,4S,5S)-6-(acetoxymethyl)
- Weitere Synonyme anzeigen
Sortieren nach
Reinheit (%)
0
100
|
0
|
50
|
90
|
95
|
100
2 Produkte.
Methyl O-2-azido-2-deoxy-3,4-bis-O-(phenylmethyl)-α-D-glucopyranosyl-(1→4)-O-2,3-bis-O-(phenylmethyl)-β-D-glucopyranuronosyl-(1→4)-O-2-azido-2-deoxy-α-D-glucopyranosyl-(1→4)-O-3-O-(phenylmethyl)-α-L-idopyranuronosyl-(1→4)-2-deoxy-2-[[(phenylmethoxy)carbonyl]amino]-3-O-(phenylmethyl)-α-D-glucopyranoside
CAS:Formel:C81H91N7O27Molekulargewicht:1594.6199Methyl-O-(2-azido-3,4-di-O-benzyl-2-deoxy-a-D-glucopyranosyl)-(1-4)-O-(2,3-di-O-benzyl-b-D-glucopyranosyluronicacid)- (1-4)-O-(2-azi do-2-deoxy-a-D-glucopyranosyl)-(1-4)-O-(3-O-benzyl-a-L-idopyranosyluronic acid)-(1-4)-3-O-benzyl- 2-benzyloxycarbonyla
CAS:<p>Maltodextrin is a polysaccharide that is made up of glucose units linked together by alpha-glycosidic bonds. Maltodextrin is commonly used as a food additive, but it also has several industrial applications. It can be used to produce escherichia coli, which is a bacterium that produces maltose and amylopectin. Maltodextrin can also be used as an animal feed supplement or as an ingredient in baby food. The glycosidic bond between the glucose units are metabolized by mouse enzymes to produce maltose and glycogen, which are both plant metabolites. Maltodextrin consists of unbranched subunits with linear chains of alpha-1,4-linked glucose residues that have alpha-1,6-linked branches at every second residue. This means that maltodextrin has a glycosidic linkage between the two glucose molecules in the chain and one of these links will always be an alpha-</p>Formel:C81H91N7O27Reinheit:Min. 95%Molekulargewicht:1,594.62 g/mol

